Bourla Albert

Albert Bourla serves as the Chairman and CEO of Pfizer Inc, overseeing the company's strategic direction and operations. His tenure has been marked by significant developments in the healthcare sector, particularly during the COVID-19 pandemic. This profile examines his insider trading activities through SEC Form 4 filings, which reveal 60 public disclosures from September 3, 2024, to July 1, 2026. Notably, his largest disclosed move was a grant/exercise valued at approximately $38.3 million on March 6, 2025, all related to Pfizer Inc (PFE), highlighting his ongoing financial engagement with the firm.